News

Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for ...
MMS, an award-winning, data-focused clinical research organization (CRO), announced today its acquisition of Exploristics, a ...
Judge Mulrooney's ruling epitomizes the DEA's institutional resistance to cannabis reform, prioritizing bureaucratic obstruction over public health and constitutional rights. As MMJ fights back in fed ...